BTW
SOLV icon

Boston Trust Walden’s Solventum SOLV Stock Holding History

Boston Trust Walden’s Portfolio SOLV Stock Details SOLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,774
Closed -$220K – 400
2025
Q4 		$220K Sell
2,774
-317
-10% -$24.3K ﹤0.01% 376
2025
Q3 		$226K Buy
3,091
+48
+2% +$3.52K ﹤0.01% 381
2025
Q2 		$231K Sell
3,043
-327
-10% -$23.2K ﹤0.01% 361
2025
Q1 		$256K Sell
3,370
-250
-7% -$18.6K ﹤0.01% 358
2024
Q4 		$239K Sell
3,620
-16
-0.4% -$1.12K ﹤0.01% 362
2024
Q3 		$254K Sell
3,636
-383
-10% -$23K ﹤0.01% 355
2024
Q2 		$213K Buy
+4,019
New +$244K ﹤0.01% 368

Other funds holding SOLV

IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Trust Walden's SOLV Position: Q1 2026 in Review

Boston Trust Walden sold out of Solventum (SOLV) in Q1 2026, closing a stake of 2,774 shares — an estimated $220K sold.

Boston Trust Walden first reported a position in SOLV in Q2 2024 and held it in 7 quarters. The position peaked at $256K in Q1 2025. 879 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Boston Trust Walden reported no remaining Solventum position as of Q1 2026 after selling out during the quarter.
  • Boston Trust Walden sold 2,774 Solventum shares in Q1 2026, an estimated $220K.
  • Boston Trust Walden first reported a position in Solventum in Q2 2024 and held it in 7 quarters.
  • Boston Trust Walden's Solventum position peaked at $256K in Q1 2025.
  • 879 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Boston Trust Walden's 13F filing for Q1 2026, filed 24 Apr 2026.